A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

NCT07203053 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

NETWORK

Sponsor class

Conditions

Extensive Stage Lung Small Cell Cancer

Interventions

DRUG: Tarlatamab

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]